Enova International grants CEO 8,313 stock options

The options vest over three annual dates; the tandem SAR depends on a qualifying Change in Control and Offer.

Available on EDGAR 11/05/2026 - 04:32 PM EST Accepted by SEC EDGAR 11/05/2026 - 04:30 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Enova International, Inc. granted CEO Steven E. Cunningham 8,313 non-qualified stock options on November 3, 2026, with an exercise price of $186.21 per share and an expiration date of November 3, 2033. The options vest in substantially equal one-third increments on November 3, 2027, November 3, 2028, and November 3, 2029, provided Cunningham remains an employee through each vesting date. The options were granted in tandem with a limited stock appreciation right: exercise of either causes the other to expire. The SAR is exercisable only following a Change in Control, and its amount is payable only if a qualifying Offer is made.

Insider Trade Summary

Grant/Award: 8,313 shares

Grant/Award 1 txn

Insider Cunningham Steven E

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Non-Qualified Stock Option (right to buy) with limited SAR F1, F2, F3	8,313	$0.00	$0.00

Holdings After Transaction: Non-Qualified Stock Option (right to buy) with limited SAR — 8,313 contracts (Direct)

Holdings Before and After: Non-Qualified Stock Option (right to buy) with limited SAR, 0 to 8,313 contracts (Direct)

Footnotes (3)

1. F1. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
2. F2. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
3. F3. The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: November 3, 2027, November 3, 2028 and November 3, 2029.

Key Figures

Options granted: 8,313 options Exercise price: $186.21 per share Option expiration: November 3, 2033 +4 more

7 metrics

Options granted 8,313 options Grant to Steven E. Cunningham on November 3, 2026

Exercise price $186.21 per share Non-qualified stock options granted November 3, 2026

Option expiration November 3, 2033 Expiration date of the granted options

Vesting schedule Substantially equal one-third increments on November 3, 2027, November 3, 2028, and November 3, 2029 Subject to continued employment through each applicable vesting date

SAR exercise period From the first day after a Change in Control through the 30th day after it Limited stock appreciation right granted in tandem with the options

Tender or exchange offer threshold At least 30% of total voting power Threshold in the definition of an Offer

Asset offer threshold 40% or more of total gross fair market value of all issuer assets Threshold in the definition of an Offer

Key Terms

Non-Qualified Stock Option, limited stock appreciation right (SAR), Change in Control, Offer Value Per Share

4 terms

Non-Qualified Stock Option financial

"Non-Qualified Stock Option (right to buy)"

A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.

limited stock appreciation right (SAR) financial

"The limited stock appreciation right ("SAR")"

Change in Control technical

"following the date that a "Change in Control" of Issuer occurs"

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

Offer Value Per Share financial

"The "Offer Value Per Share" means the average selling price"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ENVA options did Steven E. Cunningham receive?

Steven E. Cunningham received 8,313 non-qualified stock options on November 3, 2026.

What is the exercise price and expiration date of Cunningham's ENVA options?

The options have an exercise price of $186.21 per share and expire on November 3, 2033.

When do Cunningham's ENVA options vest?

The options vest in substantially equal one-third increments on November 3, 2027, November 3, 2028, and November 3, 2029, provided Cunningham remains an employee through each applicable vesting date.

When can the tandem SAR on Cunningham's ENVA options be exercised?

The SAR may be exercised from the first day after a Change in Control through the 30th day after it. Any payment requires an Offer: a qualifying tender or exchange offer representing at least 30% of voting power, or an asset-purchase offer meeting the stated 40% gross fair market value threshold; an offer made by Enova is excluded.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cunningham Steven E

(Last) (First) (Middle)

C/O ENOVA INTERNATIONAL, INC.

175 W. JACKSON BOULEVARD, SUITE 600

(Street)

CHICAGO ILLINOIS 60604

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Enova International, Inc. [ ENVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy) with limited SAR(1)(2)	$186.21	11/03/2026		A		8,313		(3)	11/03/2033	Common stock; par value $0.00001 per share	8,313	$0	8,313	D

Explanation of Responses:

1. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

2. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

3. The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: November 3, 2027, November 3, 2028 and November 3, 2029.

	/s/ Sean Rahilly, as attorney in fact	11/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)